OncoBreak: High-Tar Hookah; Dying to Be Famous; Cool Tumor Tool
News, features, and commentary about cancer-related issues
Uptake of human papillomavirus vaccine is highest among adolescent girls in high-poverty and Hispanic communities, according to an analysis of CDC data published in Cancer Epidemiology, Biomarkers & Prevention.
Laboratory studies showed that BRCA1-deficient ovarian cancer cells had reduced survival when exposed to auranofin, a drug used for decades to treat rheumatoid arthritis, British investigators reported in Mutation Research: Fundamentals and Molecular Mechanisms of Mutagenesis.
Other laboratory studies confirmed what many scientists have suspected: Large amounts of sugar may spur tumor growth and spread, as reported in Cancer Research.
Family and friends of an 8-year-old Rhode Island boy with terminal cancer have mounted a worldwide campaign to make his final wish come true: Make him famous before he dies.
The FDA has approved the OsteoCool ablation device for treating symptomatic spinal tumors, according to Medtronic, which last month acquired rights to the device from Baylis Medical.
Men who were physically active after prostate cancer diagnosis lived longer than men who lived sedentary lifestyles, according to a study reported online in European Urology.
An oncology nurse marvels at how seemingly small issues and details can make a big difference in the lives of cancer patients and the professionals who care for them.
Is President Obama's call for a "moon shot" to cure cancer a realistic goal or just political rhetoric? CNN asks several cancer experts in an attempt to separate wheat from chaff.
Thousands of cancer survivors have to deal lifelong with persistent peripheral neuropathy caused by chemotherapy, according to a study reported this week at the inaugural Cancer Survivorship Symposium.
Không có nhận xét nào:
Đăng nhận xét